Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Pawar A, Gagne JJ, Gopalakrishnan C, Iyer G, Tesfaye H, Brill G, Chin K, Bykov K. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism. JAMA. 2022 Mar 15;327(11):1051-1060. doi: 10.1001/jama.2022.1920. PMID: 35289881; PMCID: PMC8924711.
Tags
Has Results
- Has Results
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- CER Results
Journal Publication Name
- JAMA
Literature Type
- PCORI Research